Document:

Exhibit 10.1

 

AMENDED
SETTLEMENT ALLOCATION AGREEMENT

 

THIS
AMENDED SETTLEMENT ALLOCATION AGREEMENT (the “Agreement”) is made this 31st day of March, 2022, between Biofrontera Inc.,
a Delaware Corporation (“Inc”), and Biofrontera Bioscience GmbH, Biofrontera Pharma GmbH, Biofrontera Development GmbH, Biofrontera
Neuroscience GmbH, each a limited liability company organized under the laws of Germany, and Biofrontera AG (collectively, “AG”),
a corporation organized and existing under the laws of Germany. Inc and AG may be individually referred to as a “Party” or
collectively as the “Parties.”

 

WHEREAS,
on November 29, 2021, Inc and AG entered into that certain Settlement Agreement (“Settlement Agreement”), wherein the Parties
resolved various claims (the “Claims”) brought by DUSA Pharmaceuticals, Inc., Sun Pharmaceutical Industries, Inc., and Sun
Pharmaceutical Industries Ltd. (collectively “DUSA”);

 

WHEREAS,
pursuant to the terms and conditions of said Settlement Agreement, Inc and AG agreed to pay to certain amounts (as defined in Section
2(a), collectively the “Settlement Payments”) to DUSA to settle the Claims;

 

WHEREAS,
pursuant to the terms and conditions of said Settlement Agreement, Inc and AG agreed to retain the services of a forensic expert at its
own cost to assist in the destruction of certain electronically stored information to DUSA to settle the Claims;

 

WHEREAS,
pursuant to the terms and conditions of said Settlement Agreement, payment responsibility for the Settlement Payments shall be split
equally between AG and Inc; and

 

WHEREAS,
the particular breakdown of how the Settlement Payments will be made and other costs will be allocated among the Parties has been mutually
determined and agreed upon by the Parties hereto.

 

NOW,
THEREFORE, for the consideration herein, and in light of the terms contained in this Agreement, the receipt and sufficiency of which
is hereby acknowledged by the Parties, the Parties agree as follows:

 

    	1

     

    

 

AGREEMENT

 

	1.	Definitions.

 

	a.	All
                                            capitalized terms used in this Agreement shall have the same meaning as defined in the Settlement
                                            Agreement unless otherwise specifically defined herein.

 

	2.	Allocation of Settlement Payments.

 

	a.	Pursuant
                                            to the terms and conditions of the Settlement Agreement, the Parties agreed to pay to DUSA
                                            a lump sum settlement payment of US $22,500,000 (twenty-two million five hundred thousand
                                            dollars), net of any taxes, duties, or other withholdings required by law. Such Settlement
                                            Payments will be made to DUSA in three installments according to the following schedule:

 

		i.	By
                                            no later than 11:59pm EST on the 25th calendar day after the Effective Date: 50%
                                            of the Settlement Payment (the “First Installment”).

 

		ii.	By
                                            no later than 11:59pm EST on the 365th calendar day after the Effective Date:
                                            25% of the Settlement Payment, in addition to accrued interest as defined below (the “Second
                                            Installment”).

 

		iii.	By
                                            no later than 11:59pm EST on the 730th calendar day after the Effective Date:
                                            25% of the Settlement Payment, in addition to accrued interest as defined below (the “Third
                                            Installment”).

 

Pursuant
to the terms and conditions of said Settlement Agreement, payment responsibility for the Settlement Payments referenced in this section
shall be split equally between AG and Inc.

 

	b.	The
                                            Parties agree that each of the Settlement Payments shall be made, in the first instance,
                                            by Inc.

 

	c.	Following
                                            each Settlement Payment to DUSA by Inc, AG shall reimburse Inc for AG’s half of the
                                            Settlement Payment in accordance with the schedule set forth below:

 

		i.	AG
                                            shall make payment of its 50% share of the First Installment, inclusive of any taxes, duties,
                                            or other withholdings required by law, no later than January 31, 2022.

 

		ii.	AG
                                            shall make payment of its 50% share of the Second Installment, inclusive of any taxes, duties,
                                            or other withholdings required by law, no later than January 31, 2023.

 

		iii.	AG
                                            shall make payment of its 50% share of the Third Installment, inclusive of any taxes, duties,
                                            or other withholdings required by law, no later than January 31, 2024.

 

    	2

     

    

 

	3.	Allocation of Other Settlement Costs.

 

	a.	Pursuant
                                            to the terms and conditions of said Settlement Agreement, Inc and AG agreed to retain the
                                            services of a forensic expert at its own cost to assist in the destruction of certain electronically
                                            stored information.

 

	b.	The
                                            Parties agree that all costs associated with retaining the forensic expert and conducting
                                            the destruction of electronically stored information shall be incurred, in the first instance,
                                            by Inc.

 

	c.	Following
                                            the completion of the destruction of electronically stored information, Inc shall issue an
                                            invoice to AG to recoup AG’s 50% contribution to this settlement cost. AG shall make
                                            payment to Inc within 30 days of receipt of the invoice.

 

	4.	Remedies

 

	a.	If
                                            AG fails to make timely reimbursements to Inc as described in Sections 2(c) and 3(c) of this
                                            Agreement, Inc may, in its sole discretion:

 

		i.	Charge
                                            interest to AG on the amounts owed and payable under this Agreement at the rate of 6% per
                                            annum for (a) in the case of the reimbursement of the First Installment pursuant to Section
                                            2(c)(i), each day from and including January 31, 2022 until the day on which Inc has received
                                            payment in full of the amount owed, and (b) in the case of reimbursement due under Sections
                                            2(c)(ii), 2(c)(iii) and 3(c), each day from and including the day after the due date of such
                                            payment (each an “Interest Amount”);

 

		ii.	Offset
                                            the amounts owed and payable under this Agreement, including any applicable Interest Amount,
                                            against payments owed to AG by Inc under separate agreements duly executed between the parties,
                                            including but not limited to amounts owed under a certain License and Supply Agreement, made
                                            effective June 16, 2021 and as amended thereafter (collectively, the “LSA”) such
                                            that any amounts owed to AG by Inc are reduced by amounts owed and payable, at the time of
                                            such payment that is being offset, to Inc by AG under this Agreement and the amount by which
                                            such payment is offset will be deemed to have been paid by AG to Inc in satisfaction (full
                                            or partial, as applicable) of its reimbursement obligations under this Agreement; provided
                                            that, Inc may elect to offset a payment to AG by less than the total amount owed and payable
                                            under this Agreement at the time of such payment and, further provided that, if Inc’s
                                            payment is reduced by less than the total amount owed and payable under this Agreement at
                                            the time of such payment, the difference between (i) the total amount owed and payable at
                                            the time of such payment and (ii) the amount by which Inc’s payment has been reduced,
                                            will remain owed and payable to Inc by AG and may be used to offset subsequent payments by
                                            Inc to AG; and/or

 

		iii.	Exercise
                                            all other rights and remedies available to Inc under applicable law and pursue any and all
                                            available remedies for collection of such amounts owed and payable under this Agreement and
                                            any applicable Interest Amounts.

 

	b.	If
                                            any action at law or in equity is necessary to enforce or interpret the terms of this Agreement,
                                            the prevailing party shall be entitled to collect from the other party all reasonable attorneys’
                                            fees, costs and necessary disbursements incurred in such action (in addition to any other
                                            relief to which the prevailing party may be entitled).

 

    	3

     

    

 

	5.	Miscellaneous

 

	a.	Entire
                                            Agreement; Consistency with LSA. This Agreement contains the entire understanding between
                                            and among the parties and supersedes any prior understandings and agreements among them respecting
                                            the subject matter of this Agreement. Except as amended by this Agreement, the Settlement
                                            Agreement shall continue to be unchanged and the Settlement Agreement as amended by this
                                            Agreement sets forth the entire agreement between Inc and AG with respect to the subject
                                            matter contemplated therein. No amendment to the Settlement Agreement or this Agreement shall
                                            be effective unless in writing and signed by the Parties. The Parties expressly agree that
                                            this Agreement shall be construed as being consistent with the terms of the LSA and shall
                                            not impact the rights and responsibilities of the parties to the LSA in any way other than
                                            as described in Section 4(b) with regard to Inc’s ability to offset amounts owed to
                                            it by AG under the LSA.

 

	b.	Notices.
                                            Except as otherwise provided herein, all notices, requests, demands, consents, instructions
                                            or other communications to or upon Lender or Borrower under this Agreement or the other Loan
                                            Documents shall be in writing and telecopied, mailed or delivered to each party at its telecopier
                                            number or address set forth below (or to such other telecopier number or address for any
                                            party as indicated in any notice given by that party to the other party). All such notices
                                            and communications shall be effective (i) when sent by Federal Express or other overnight
                                            service of recognized standing, on the Business Day following the deposit with such service;
                                            (ii) when mailed by registered or certified mail, first class postage prepaid and addressed
                                            as aforesaid through the United States or German Postal Service, upon receipt; (iii) when
                                            delivered by hand, upon delivery; and (iv) when telecopied, upon confirmation of receipt;
                                            provided, however, that any notice delivered to Lender under Section 2 shall not be effective
                                            until received by Lender.

 

	 	AG:	Biofrontera AG
	 	 	Hemmelrather Weg 201
	 	 	51377 Leverkusen Germany
	 	 	Attention: Ludwig Lutter
	 	 	 
	 	INC:	Biofrontera Inc.
	 	 	120 Presidential Way, Suite 330
	 	 	Woburn, MA 01801
	 	 	Attention: Erica Monaco

 

	c.	Waivers;
                                            Amendments. Any term, covenant, agreement or condition of this Loan Agreement or any
                                            other Loan Document may be amended or waived if such amendment or waiver is in writing and
                                            is signed by Borrower and Lender. No failure or delay by Lender in exercising any right hereunder
                                            shall operate as a waiver thereof or of any other right nor shall any single or partial exercise
                                            of any such right preclude any other further exercise thereof or of any other right. A waiver
                                            or consent given hereunder shall be effective only if in writing and in the specific instance
                                            and for the specific purpose for which given.

 

    	4

     

    

 

	d.	Successors
                                            and Assigns. This Loan Agreement and the other Loan Documents shall be binding upon and
                                            inure to the benefit of Borrower, Lender and their respective successors and permitted assigns,
                                            except that Borrower may not assign or transfer (and any such attempted assignment or transfer
                                            shall be void) any of its rights or obligations under any Loan Document without the prior
                                            written consent of Lender.

 

	e.	Term
                                            and Termination. This Agreement shall remain in full force unless terminated by mutual
                                            written consent of the Parties. Neither Party may terminate this agreement without written
                                            consent of the other.

 

	f.	Counterparts.
                                            This Agreement may be executed by facsimile signature and in one or more counterparts, all
                                            of which shall be considered one and the same agreement and shall become effective when one
                                            or more counterparts have been signed by each of the parties and delivered to the other parties.

 

	g.	Governing
                                            Law. This Agreement shall be governed by and construed in accordance with the laws of
                                            the State of Massachusetts, USA. The parties hereto hereby agree that any suits brought hereunder
                                            shall be brought in a State or Federal Court of competent jurisdiction located in Boston,
                                            Massachusetts, which will have sole and exclusive jurisdiction for claims arising from this
                                            Agreement.

 

[Remainder
of page intentionally left blank; Signature page follows]

 

    	5

     

    

 

IN
WITNESS WHEREOF, the parties have executed this Amended Settlement Allocation Agreement, effective as of the date first set forth above.

 

	Biofrontera AG	 	 
	Biofrontera Bioscience GmbH	 	 
	Biofrontera Pharma GmbH	 	 
	Biofrontera Development GmbH	 	 
	Biofrontera Neuroscience GmbH	 	Biofrontera Inc.
	 	 	 
	Signature:	/s/ Ludwig Lutter	 	Signature:	/s/ Erica Monaco
	 	 	 
	Date:	4/1/2022	 	Date:	3/31/2022
	 	 	 
	Name:	Ludwig Lutter	 	Name:	Erica Monaco
	 	 	 
	Title:	Chief Financial Officer	 	Title:	Chief Executive Officer

 

    	6Exhibit
10.2

 

 

AMENDMENT
TO EMPLOYMENT AGREEMENT

 

This
Amendment to Employment Agreement (the “Amendment”) is made effective as of April 1, 2022 (the “Effective Date of this
Amendment”), by and between Biofrontera, Inc, a Delaware corporation (the “Company”) having its registered office at
120 Presidential Way, Suite 330, Woburn, MA 01801 and Erica Monaco (the “Executive”), currently employed as Chief Executive
Officer for Biofrontera Inc.

 

Recitals

 

Whereas,
the Parties entered into a certain Employment Agreement on August 11, 2021, (the “Agreement”); and

 

Whereas,
the Parties with to amend certain terms of the Agreement, as described herein.

 

Now,
therefore, in consideration of the foregoing and the agreements contained here, the Parties hereto, intending to be legally bound,
hereby agree as follows:

 

Agreement

 

	 	1.	Amendment
    to Agreement. As of the Effective Date of this Amendment:

 

	 	a.	Section
    4 of the Agreement shall be amended to read in its entirety as follows (added language appears in italics, deleted language
    appears in strikethrough):

 

“COMPENSATION

 

For
the services to be rendered by the Executive under the Agreement, the Company shall pay her a salary while she is rendering such services
and performing her duties hereunder, and the Executive shall accept such salary as full payment for such service. Executive’s annual
base salary shall be $300,000.00$450,000.00, reduced by (i) Federal income tax withholding, (ii) FICA; and (iii)
such other reductions as may be agreed upon by the parties or required by law, and shall be paid in bi-weekly installments and in accordance
with the Company’s customary payroll procedure. For each fiscal year in effect during the active life of this Agreement, the Executive
shall be eligible to receive a cash bonus of up to 30 60% of her base salary (the “Target Bonus”)
upon the attainment of performance goals set in advance by the Board of Directors. All such bonuses shall be paid after the completion
of the Company’s financial statements for the applicable fiscal year as and when bonuses are paid to members of senior management
generally. The actual amount of Executive’s bonus shall depend upon the level of achievement of set targets, however no bonus shall
be paid if the level of target achievement is below 70%.

 

    	1

    	 

    

 

 

Company
shall also pay to Executive a one-time signing bonus of $75,000.00 (subject to applicable tax withholdings). This sum shall be paid in
two installments: i) $37,500.00 on the first regularly scheduled pay date after the effective date of this Agreement, and ii) $37,500.00
on the final pay date of 2021 (provided that this Agreement has not been terminated by either party in accordance with Section 9 of this
Agreement prior to said date).

 

Upon
the Executive’s termination of employment, regardless of the reason for such termination and regardless of the party by whom such
termination is initiated, the Executive shall be entitled to immediate payment of all accrued but unpaid base salary and expenses owed.
In addition, upon the Executive’s termination of employment by the Company other than termination for “Cause” under
Section 9(d) of the Agreement, the Executive shall be entitled to a severance payment equal to one twelfth the Executive’s then-current
annual base salary for each full year the Executive has been employed by the Company (including Biofrontera AG, as a past affiliate of
the Company); provided, however, that such payment shall not exceed two full years of Executive’s then-current base salary.

 

Further,
the Executive shall participate in Company’s stock option plan. The number of options rewarded to her shall be at the discretion
of the Board of Directors.”

 

	 	2.	Continuing
    Effect of Original Agreement. 

 

	 	a.	This
    Amendment shall only serve to amend and modify the Employment Agreement to the extent specifically provided herein. All terms, conditions,
    provisions, exhibits and references of and to the Employment Agreement that are not specifically modified and/or amended herein shall
    remain in full force and effect and shall not be altered by any provisions herein contained. On and after the date of this Amendment,
    each reference in the Employment Agreement to “this Agreement,” “hereunder,” “hereof,” “herein”
    or words of like import, and each reference to the Employment Agreement, including the exhibits relating thereto, in any other agreements,
    documents or instruments executed and delivered pursuant to the Employment Agreement, shall mean and be a reference to the Employment
    Agreement as amended by this Amendment. 
	 	 	 
	 	b.	For
    the avoidance of doubt, the Parties agree that the first payment made to Executive under the Agreement shall include a “catch
    up” payment to account for all sums owed to Executive that were accrued between the Effective Date and the date on which this
    Amendment was executed. 

 

	 	3.	Capitalized
    Terms. 

 

	 	a.	All
    capitalized terms not defined herein shall have the meaning ascribed to them in the Agreement. In the event of a conflict between
    the capitalized terms defined and set forth in this Amendment and the defined terms of the Agreement, the definitions set forth in
    this Amendment shall control.

 

[Remainder
of page intentionally left blank; Signature page follows.]

 

    	2

    	 

    

 

 

IN
WITNESS WHEREOF, the parties have executed the Agreement,

 

	Biofrontera
    Inc.	 	 
	 	 	 
	/s/
    Hermann Luebbert	 	4/1/2022
	Prof.
    Dr. Hermann Luebbert	 	Date
	Executive
    Chairman	 	 
	Chairman
    of the Board of Directors	 	 
	 	 	 
	Executive	 	 
	 	 	 
	/s/
    Erica Monaco	 	4/1/2022
	Erica
    Monaco	 	Date

 

    	3

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00343-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00343-of-00352.parquet"}]]